Study guide

16.1 Pattern Recognition: Obstruction, Restriction, Mixed, Severity

NBRC Registered Pulmonary Function Technologist RPFT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Content Outline Domains & Study Plan

2 Spirometry Instrumentation

2.1 Spirometer Types, Setup & Maintenance 2.2 Spirometer Calibration & Linearity 2.3 Spirometer Troubleshooting

3 Blood Gas & Gas Analyzers

3.1 Blood Gas Analyzer Setup, Maintain, Calibrate 3.2 Gas Analyzers & Water/Gas Absorbers 3.3 ABG & Gas Analyzer Troubleshooting and QC

4 Body Box, Exercise & Monitoring Equipment

4.1 Body Plethysmograph Setup & Calibration 4.2 Exercise, Field Walking & ECG Equipment 4.3 Pressure Devices, Valves & Gas Delivery Systems

5 Ancillary Equipment & Infection Control

5.1 Body Habitus, Sampling & Aerosol Equipment 5.2 Monitors & Emergency Management Equipment 5.3 Infection Control Materials & Methods

6 Quality Control Systems

6.1 Mechanical QC Devices 6.2 Biological Controls & Proficiency Testing 6.3 Laboratory Quality Management & SOPs

7 Patient Preparation & Safety

7.1 Body Habitus Measurements & Estimates 7.2 Patient Safety, Precautions & Adverse Events

8 Spirometry Procedures

8.1 Selecting Spirometry Protocols & Equipment 8.2 Performing Standard & Position-Variant Spirometry 8.3 Evaluating Spirometry Acceptability & Repeatability 8.4 Bronchodilator Response Studies

9 Static Lung Volumes

9.1 Gas Dilution Lung Volume Methods 9.2 Body Plethysmography Lung Volumes 9.3 Evaluating Lung Volume Validity

10 Diffusing Capacity (DLCO)

10.1 DLCO Protocol & Equipment Selection 10.2 Performing the DLCO Maneuver 10.3 Evaluating DLCO Validity

11 Blood Gas Sampling & Analysis Procedures

11.1 Arterial & Capillary Blood Sample Collection 11.2 Performing Blood Gas Analysis 11.3 CO-oximetry / Hemoximetry Procedures

12 Airway Responsiveness, Resistance & Muscle Strength

12.1 Bronchial Provocation Studies 12.2 Airways Resistance & Conductance by Plethysmography 12.3 Respiratory Muscle Strength (MIP/MEP/CPF)

13 Exercise, Oxygen, Home Testing & Education

13.1 Field Walking Tests (6MWT, Shuttle) 13.2 Monitored Exercise Testing 13.3 Oxygen Assessment & Titration 13.4 Home Testing Instruction & Patient Education

14 Calculations & Reference Ranges

14.1 Spirometry Calculations & Reference Equations 14.2 Lung Volume & DLCO Calculations/Corrections 14.3 Blood Gas & CO-oximetry Derived Calculations 14.4 Exercise, Oximetry & Special Test Calculations

15 Evaluating Result Reliability

15.1 Spirometry & Lung Volume Reliability 15.2 DLCO & Exercise Test Reliability 15.3 ABG, Monitoring & QC Reliability

16 Clinical Implications & Reporting

16.1 Pattern Recognition: Obstruction, Restriction, Mixed, Severity 16.2 Clinical Implications: DLCO, ABG, Airway Response, Exercise & Lab Context

16.1 Pattern Recognition: Obstruction, Restriction, Mixed, Severity

Key Takeaways Explain This Topic AI

Obstruction is defined primarily by a reduced FEV1/FVC (or FEV1/VC) relative to LLN/z-score; TLC and RV help stage air trapping and hyperinflation, not the ratio diagnosis alone.

Restriction requires a reduced TLC (after reliable volumes); a low FVC with normal/high FEV1/FVC only suggests possible restriction until volumes confirm it.

Mixed pattern = obstruction plus reduced TLC; do not call mixed from spirometry alone without volumes.

Severity framing for reports uses %predicted and/or z-scores as laboratory literacy—not a physician diagnosis label written as fact without clinical context.

Flow-volume shapes (scooped expiratory limb, tall peaked restriction, variable extra-/intrathoracic upper-airway flattening) are high-yield RPFT pattern cues when effort and acceptability are established.

Last updated: August 2026

Domain III.C: From Clean Data to Clinical Pattern Language

Domain III.B asked whether results are reliable . Domain III.C — Clinical implications asks what the clean numbers mean for the referring clinician and how the pulmonary function technologist frames them on the report. On the NBRC PFT Examination (high cut / RPFT), pattern items map to III.C.3.a/b (obstructive patterns and severity cues), III.C.4.a/b (restrictive and mixed patterns), III.C.12 (bronchodilator response implications), and III.C.17–18 (serial change and integrated interpretation literacy).

You are not writing a discharge diagnosis. You are expected to:

Recognize classic physiologic patterns (obstruction, restriction, mixed).

Apply severity framing using %predicted and/or z-scores at technologist reporting literacy .

Read flow-volume loop morphology after effort is established.

Integrate volumes with spirometry before calling restriction.

State bronchodilator and serial change findings clearly without over-claiming etiology.

  • Classic Patterns: Obstruction, Restriction, Mixed
  • Obstructive pattern (airflow limitation)

Primary spirometric signal: reduced FEV1/FVC (or FEV1/VC) below the lower limit of normal (LLN) or a sufficiently negative z-score , with acceptable, repeatable efforts.

  • Feature Typical obstructive finding Reporting note
  • FEV1/FVC (or FEV1/VC) Reduced vs LLN/z-score Defines obstruction pattern on spirometry
  • FEV1 Often reduced Used heavily for severity framing once ratio is low
  • FVC Normal or reduced Reduced FVC does not equal restriction if ratio is low
  • TLC Normal or increased Hyperinflation supports severe obstruction / air trapping context
  • RV / RV/TLC Often increased Air trapping signal when volumes reliable
  • MEFV shape Concave / “scooped” expiratory limb High-yield morphology cue

Exam rule: Low FEV1 with a normal ratio is not classic obstruction. Look for restriction, effort issues (already filtered in III.B), or mixed/other patterns after volumes.

Hyperinflation vs obstruction: Elevated TLC/RV supports the physiologic story of air trapping but does not replace a reduced ratio as the obstructive gate.

Restrictive pattern

Primary volume signal: reduced TLC (after reliable FRC/TGV method and VC linkage).

  • Feature Typical restrictive finding Reporting note
  • TLC Reduced Required to confirm restriction
  • FEV1/FVC Normal or high High ratio is common when FVC falls more than FEV1
  • FVC / VC Reduced Suggests restriction only— not confirmatory alone
  • RV Variable (often low-normal or reduced in simple restriction) Context-dependent
  • MEFV shape Tall, narrow, peaked (“witch’s hat”) possible Morphology supports, does not replace TLC

Critical RPFT trap: Reporting “restriction” from low FVC + normal ratio without volumes is incomplete . Many labs phrase this as “possible restriction—volumes recommended” or wait for TLC. Domain III.C expects you to know that spirometry can only suggest restriction; TLC confirms it.

Mixed pattern

Definition for pattern literacy: airflow limitation (low FEV1/FVC vs LLN) plus reduced TLC .

  • Finding Obstruction alone Restriction alone Mixed
  • FEV1/FVC ↓ NL/↑ ↓
  • TLC NL/↑ ↓ ↓
  • RV Often ↑ Often ↓/NL Variable (may be relatively high for the low TLC)

Do not call mixed because FVC is low in pure obstruction (air trapping can reduce FVC without true restriction). Volumes decide.

Severity Framing (%predicted and z-scores)

Severity language on the exam is reporting literacy , not freestanding physician diagnosis. After a pattern is established on reliable data:

%predicted remains widely used on reports and in many DCO-style stems (e.g., FEV1 %predicted bands for obstructive severity framing).

z-scores / LLN are the modern ATS/ERS-aligned way to define abnormal vs normal relative to reference equations (e.g., GLI).

Severity grades (mild/moderate/severe) are applied to indices (commonly FEV1 once obstruction is present; TLC or FVC framing in restriction contexts per lab protocol)—always subordinate to pattern definition.

  • Literacy point Technologist action Over-reach to avoid
  • Abnormal vs normal Compare to LLN/z-score for the chosen reference set Inventing disease names from one number

Severity band Report %predicted (and z-score if used) clearly Claiming “Stage 3 COPD” as if GOLD clinical staging were complete from PFT alone

  • Mixed disease State both obstructive and restrictive signals Picking only the more dramatic number
  • Pediatric / extreme anthropometrics Mind reference applicability Forcing adult fixed cutoffs

Worked mini-example (framing, not diagnosis): Acceptable spirometry shows FEV1/FVC below LLN, FEV1 48% predicted, TLC 110% predicted, RV elevated. Pattern: obstruction with hyperinflation/air-trapping context. Severity framing: moderate-to-severe reduction in FEV1 by %predicted convention used in the stem— not a final clinical stage without the ordering clinician’s synthesis.

Flow-Volume Loop Shape Cues (High-Yield for RPFT)

Morphology is powerful after Domain II/III.B effort gates are clean.

Shape cue Classic association What to verify first

Scooped / concave expiratory limb Intrabronchial airflow limitation (obstruction) Acceptable peak, repeatable FEV1, ratio ↓

Tall, peaked, narrow loop Restriction (small volumes, relatively high flows) TLC confirmation when available

Variable extrathoracic upper airway Flattened inspiratory limb (variable) Effort on inspiration; repeatability of flattening

Variable intrathoracic upper airway Flattened expiratory limb (variable plateau) Distinguish from ordinary scoop; clinical referral context

  • Fixed upper airway Flattened both inspiratory and expiratory limbs Consistent plateaus across efforts
  • Sudden drop / cough / early termination Technical artifact Do not pattern-label until corrected

Exam contrast stems love upper-airway vs ordinary obstruction:

Variable extrathoracic: inspiratory plateau/flattening more than expiratory scoop.

Variable intrathoracic: expiratory flattening/plateau pattern distinct from smooth concavity of small-airway obstruction.

Fixed lesion: both limbs truncated.

Always couple shape language with numeric indices . A pretty scoop without a reduced ratio is not automatic obstruction; a reduced ratio without morphology still can be obstruction if efforts are maximal and repeatable.

Integrating Volumes with Spirometry Before Calling Restriction

Workflow for III.C.4 literacy:

Spirometry first: ratio low → obstruction pathway; ratio NL/high with low FVC → possible restriction.

Obtain reliable TLC (box preferred when air trapping suspected; dilution method limitations noted).

TLC reduced → restriction confirmed (or mixed if ratio also low).

TLC normal/high with low FVC and low ratio → obstruction with air trapping / incomplete emptying, not mixed restriction.

TLC normal with isolated low FVC and normal ratio → re-check effort, neuromuscular, or non-pulmonary causes; do not force interstitial disease on the report.

Case vignette A — False restriction. FVC 62% predicted, FEV1/FVC 0.82, no volumes. Junior staff labels “moderate restriction.” Later box TLC is 98% predicted. Correct pattern language: spirometry suggested restriction but TLC excludes it; investigate effort, early termination history, or extra-thoracic/process issues—do not finalize restriction on FVC alone.

Case vignette B — True mixed. FEV1/FVC below LLN, FEV1 55% predicted, TLC 68% predicted with reliable pant loops. Pattern: mixed obstructive and restrictive. Report both signals; severity framing applies to the reduced indices per lab convention.

Case vignette C — Obstruction with air trapping. Ratio reduced, FVC low, TLC 125% predicted, RV/TLC high. Not mixed. Hyperinflation/air trapping explains the low FVC in an obstructive framework.

  • Bronchodilator Response and Serial Change (III.C.12, III.C.17–18)
  • Bronchodilator (BD) response — clinical meaning for reports

After pre/post testing with acceptable efforts:

A significant BD response (lab/ATS-aligned thresholds for FEV1 and/or FVC improvement) supports reversible airflow limitation for the referring clinician—often relevant to asthma/AFO management discussions.

A negative BD study does not prove “not asthma” and does not prove irreversible COPD by itself; it means no significant acute response under test conditions .

Always report pre and post absolute values, % change, and absolute change , plus which post-BD set was selected under lab rules.

  • Report element Why it matters clinically
  • Pre-BD pattern Baseline obstruction severity framing
  • Post-BD FEV1/FVC and FEV1 Residual obstruction vs near-normalization
  • Magnitude of response Guides clinician consideration of reversible component
  • Technical notes Incomplete post efforts invalidate BD conclusions
  • Serial change — reporting literacy

Serial PFTs compare visits after each session is reliable:

Meaningful change exceeds expected biologic + measurement variability (stems may give % or absolute thresholds).

Improvement after therapy vs decline suggesting progression are clinical uses —the technologist’s job is accurate paired reporting, same reference set awareness, and flagging method differences (e.g., different volume techniques across years).

Do not equate a single noisy visit-to-visit wobble with “rapid progression.”

Case vignette D — BD. Pre FEV1 1.80 L (55% pred), post 2.20 L after albuterol with repeatable efforts; ratio improves but remains below LLN. Report: significant BD response with residual obstruction—useful for the ordering clinician; still an obstructive pattern post-BD if ratio remains reduced.

Integrated Reporting Checklist (Pattern Section)

Confirm III.B reliability for the indices you will pattern-label.

Classify obstruction from ratio/LLN (spirometry).

Confirm restriction only with reduced TLC (or clearly state volumes pending).

Reserve mixed for low ratio and low TLC.

Add severity framing with %predicted/z-score language appropriate to the indices.

Describe flow-volume morphology when it adds upper-airway or classic scoop/peak cues.

Attach BD response and serial change as separate, numeric statements—not free-text diagnoses.

Domain III.C.3, III.C.4, III.C.12, and III.C.17–18 reward technologists who speak pattern language precisely, integrate volumes before restriction , and keep severity and BD/serial statements at the reporting level the exam expects—clear, physiologic, and never a substitute for the physician’s clinical diagnosis.